Company: BIAF
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004915
Chunk: 182

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: DRS
Chunk 182
---
 is no minimum number of securities or amount of proceeds that is a condition to closing of this offering.

Fees and Expenses

The following table shows the per share and accompanying April 2025 Warrants and per Pre-Funded Warrant and accompanying April 2025 Warrants Placement Agent fees we will pay in connection with the sale of the securities in this offering, assuming the purchase of all of the securities we are offering.

| Per share of Common Stock and                             
 accompanying April 2025 Warrant–Placement Agent cash fees |     | $ |
| Per Pre-Funded Warrant and accompanying                   
 April 2025 Warrant –Placement Agent cash fees             |     | $ |
| Total                                                     |     | $ |

We have agreed to pay the Placement Agent a total
cash fee equal to 8.0% of the gross proceeds of this offering. We will also reimburse the Placement Agent’s legal fees and
expenses in an amount up to $135,000. We estimate the total offering expenses of this offering that will be payable by us, excluding
the Placement Agent fees and expenses, will be approximately $[___]. After deducting the Placement Agent fees and our estimated offering
expenses, we expect the net proceeds from this offering to be approximately $[___] million.

Placement Agent Warrants

We have also agreed to issue to the Placement Agent (or its designees) Placement Agent Warrants to purchase up to [__] shares of Common Stock. The Placement Agent Warrants will have substantially the same terms as the April 2025 Warrants described above, except that the Placement Agent Warrants will have an exercise price of $[__] per share (representing 115% of the combined public offering price per share of Common Stock and accompanying April 2025 Warrant) and a termination date that will be five years from the commencement of the sales pursuant to this offering. The Placement Agent Warrants are registered on the registration statement of which this prospectus is a part. The form of the Placement Agent Warrants is included as an exhibit to this registration statement of which this prospectus forms a part.

| 90 |

Right of First Refusal

In addition, with certain exceptions, for a period of six months following the closing of this offering, if we decide to raise funds by means of a public offering (including “at the market offering” facility) the right to act as sole book-running manager, sole underwriter or sole placement agent for such financing.

Tail

We have also agreed to pay the Placement Agent